Legal Status This site displays a prototype of a “Web 2.0” version of the daily
Federal Register. It is not an official legal edition of the Federal
Register, and does not replace the official print version or the official
electronic version on GPO’s govinfo.gov.

The documents posted on this site are XML renditions of published Federal
Register documents. Each document posted on the site includes a link to the
corresponding official PDF file on govinfo.gov. This prototype edition of the
daily Federal Register on FederalRegister.gov will remain an unofficial
informational resource until the Administrative Committee of the Federal
Register (ACFR) issues a regulation granting it official legal status.
For complete information about, and access to, our official publications
and services, go to About the Federal Register on NARA's archives.gov.

The OFR/GPO partnership is committed to presenting accurate and reliable
regulatory information on FederalRegister.gov with the objective of
establishing the XML-based Federal Register as an ACFR-sanctioned
publication in the future. While every effort has been made to ensure that
the material on FederalRegister.gov is accurately displayed, consistent with
the official SGML-based PDF version on govinfo.gov, those relying on it for
legal research should verify their results against an official edition of
the Federal Register. Until the ACFR grants it official status, the XML
rendition of the daily Federal Register on FederalRegister.gov does not
provide legal notice to the public or judicial notice to the courts.

Legal Status

Notice

You may be interested in this older document that published on 02/03/2026 View Document

Self-Regulatory Organizations; Cboe BZX Exchange, Inc.; Order Granting Approval of a Proposed Rule Change To Amend Exchange Rule 14.12

A Notice by the Securities and Exchange Commission on 03/16/2026

• 1.

1.

• Document Details Published Content - Document Details Agency Securities and Exchange Commission Agency/Docket Numbers Release No. 34-104970 File No. SR-CboeBZX-2026-005 Document Citation 91 FR 12650 Document Number 2026-05022 Document Type Notice Pages 12650-12652
  (3 pages) Publication Date 03/16/2026 Published Content - Document Details

• PDF Official Content

  • View printed version (PDF) Official Content

• Document Details Published Content - Document Details Agency Securities and Exchange Commission Agency/Docket Numbers Release No. 34-104970 File No. SR-CboeBZX-2026-005 Document Citation 91 FR 12650 Document Number 2026-05022 Document Type Notice Pages 12650-12652
  (3 pages) Publication Date 03/16/2026 Published Content - Document Details

• Table of Contents Enhanced Content - Table of Contents This table of contents is a navigational tool, processed from the
  headings within the legal text of Federal Register documents.
  This repetition of headings to form internal navigation links
  has no substantive legal effect.

  • Footnotes Enhanced Content - Table of Contents

• Related Documents Enhanced Content - Related Documents FederalRegister.gov uses the agency dockets published with the document to display related documents.

| File No. SR-CboeBZX-2026-005
(2 Documents) | | | |
| --- | | | |
| Date | | Action | Title |
| | 2026-03-16 | | Self-Regulatory Organizations; Cboe BZX Exchange, Inc.; Order Granting Approval of a Proposed Rule Change To Amend Exchange Rule 14.12 |
| | 2026-02-03 | | Self-Regulatory Organizations; Cboe BZX Exchange, Inc.; Notice of Filing of a Proposed Rule Change To Amend Exchange Rule 14.12 |

Enhanced Content - Related Documents

• Public Comments Enhanced Content - Public Comments This feature is not available for this document.

Enhanced Content - Public Comments
- Regulations.gov Data Enhanced Content - Regulations.gov Data Additional information is not currently available for this document.

Enhanced Content - Regulations.gov Data

- Sharing Enhanced Content - Sharing Shorter Document URL https://www.federalregister.gov/d/2026-05022 Email Email this document to a friend Enhanced Content - Sharing

• Print Enhanced Content - Print
  • Print this document Enhanced Content - Print
• Document Statistics Enhanced Content - Document Statistics Document page views are updated periodically throughout the day and are cumulative counts for this document. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.

Page views 16
as of
03/14/2026 at 2:15 pm EDT Enhanced Content - Document Statistics
- Other Formats Enhanced Content - Other Formats This document is also available in the following formats:

JSON Normalized attributes and metadata XML Original full text XML MODS Government Publishing Office metadata More information and documentation can be found in our developer tools pages.

Enhanced Content - Other Formats
- Public Inspection Public Inspection This PDF is FR Doc. 2026-05022 as it appeared on Public Inspection on
03/13/2026 at 8:45 am.

It was viewed
4
times while on Public Inspection.

If you are using public inspection listings for legal research, you
should verify the contents of the documents against a final, official
edition of the Federal Register. Only official editions of the
Federal Register provide legal notice of publication to the public and judicial notice
to the courts under 44 U.S.C. 1503 & 1507. Learn more here.

Public Inspection
Published Document: 2026-05022 (91 FR 12650) This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Document Headings Document headings vary by document type but may contain
the following:

1. the agency or agencies that issued and signed a document
2. the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to
3. the agency docket number / agency internal file number
4. the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details.

Securities and Exchange Commission

1. [Release No. 34-104970; File No. SR-CboeBZX-2026-005] March 11, 2026. ## I. Introduction

On January 29, 2026, Cboe BZX Exchange, Inc. (“Exchange” or “BZX”) filed with the Securities and Exchange Commission (“Commission”), pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934 (“Act”) [1 ] and Rule 19b-4 thereunder, [2 ] a proposed rule change to amend Exchange Rule 14.12 (Failure to Meet Listing Standards) to authorize the Listing Qualifications Department (“Exchange Staff”) to grant an issuer of a security listed or applying to list on the Exchange (“Company”) an additional 180-day compliance period for deficiencies related to the beneficial holder continued listing requirement that require submission of a Plan of Compliance under Rule 14.12(f). [3 ] The Commission has received two comments on the proposal. [4 ] As discussed further below, this order approves the proposed rule change.

II. Description of the Proposal

As described in greater detail in the Notice, Exchange Rule 14.12 generally governs the procedures for the independent review, suspension, and delisting of Companies that fail to satisfy one or more standards for initial or continued listing on the Exchange. [5 ] When Exchange Staff determines that a Company does not meet a listing standard, including the beneficial holder continued listing requirement, Exchange Staff will immediately notify the Company of the deficiency; and, unless the Company is currently under review by an Adjudicatory Body for an Exchange Staff Delisting Determination, Exchange Staff may accept and review a plan to regain compliance (a “Company Compliance Plan”). [6 ] Upon review of a Company Compliance Plan, the Exchange may grant an extension of time to regain compliance not greater than 180 calendar days from the date of Exchange Staff's initial notification. [7 ]

The Exchange proposed to adopt new Exchange Rule 14.12(f)(2)(B)(ii) to permit Exchange Staff to grant an additional cure period of 180 calendar days for deficiencies related to the beneficial holders continued listing requirement, with such total cure period not to exceed a total of 360 calendar days from the date of the Exchange's initial notification. [8 ] The proposed rule change applies to all exchange-traded products (“ETPs” or “products”) eligible to list pursuant to Exchange Rule 14.11, and any issuer that demonstrates quantifiable progress toward compliance with the beneficial holder requirement during the initial 180-day compliance period may be granted the additional time at Exchange Staff's discretion. [9 ]

III. Discussion, Comments, and Commission Findings

The Exchange states that, given that the beneficial holder requirement is a quantifiable standard, Exchange Staff can readily assess whether a product is nearing compliance by reviewing periodic beneficial holder counts and determining whether the product has shown measurable improvement, and may consider whether the beneficial holder count has increased by a meaningful percentage during the initial compliance period, whether the rate of holder accumulation is accelerating, or whether the product has achieved a threshold number of holders indicating that compliance is likely within the ( printed page 12651) extended period. [10 ] The Exchange states that this discretionary approach ensures that the additional 180 days is granted only to products demonstrating genuine progress toward compliance. [11 ]

While the proposed rule change applies uniformly to all products, the Exchange states that certain products—for example, “Outcome Strategy ETPs”—may face unique challenges in achieving beneficial holder requirements within the initial 180-day timeframe, particularly where a tranche of funds that seeks to achieve its investment objective through a laddered portfolio of the fund's investment in multiple underlying ETFs that have outcome period expiration dates which occur on a rolling, or staggered, basis and where each tranche represents a different starting point within the same overall strategy. [12 ] The Exchange believes that the threat of delisting to a single tranche of such a series impairs the fund manager's ability to distribute and maintain the entire series and, unlike ETPs where one product's delisting does not affect other products, laddered portfolios are marketed, distributed, and understood by investors as complete series. [13 ] The Exchange states that an incomplete series may cause market participants to abandon the entire product resulting in asset outflows and beneficial holder reductions across all tranches, including those in full compliance with listing standards. [14 ] The Exchange states that many investors in Outcome Strategy ETFs roll assets into the next “front-month” or near-dated tranche as their current holdings approach expiration, and near-term tranches may accumulate assets and beneficial holders while tranches further from expiration tend to see less interest, fewer assets, and fewer beneficial holders. [15 ] Thus, tranches farther from expiration may temporarily fall below the beneficial holder threshold during their early life, but cure as they become front-month tranches and attract rolling assets from maturing positions. [16 ] The Exchange states that the initial 180-day timeframe may be insufficient for a newly-launched or back-dated tranche to progress through this natural maturation cycle and benefit from the rolling behavior that drives holder accumulation. [17 ]

The Exchange states that the proposed extended compliance period provides issuers with sufficient time to implement comprehensive remediation strategies that stabilize integrated product series, protecting the interests of holders across all tranches and preventing unnecessary market disruption. [18 ] The Exchange states that the extended compliance period can apply to any product where premature delisting based on temporary beneficial holder deficiencies could harm investors when the issuer is making measurable progress toward compliance. [19 ] The Exchange further states that a 180-day compliance period may be insufficient in certain circumstances where issuers are making genuine progress toward compliance but require additional time to achieve the listing standard due to product-specific characteristics, market conditions, or other factors affecting beneficial holder accumulation; and that the additional cure period provides appropriate flexibility to prevent premature delistings of products that are demonstrably moving toward compliance. [20 ]

The Commission received two comment letters, both supporting the proposed rule change. [21 ] One commenter acknowledged that it can be challenging for new funds to develop a broad shareholder base, and stating that the additional compliance period would not be an automatic or indefinite extension of the compliance period, but instead permits the Exchange to take into account tangible progress toward meeting the beneficial holder requirement. [22 ] Another commenter stated that the proposed rule change provides a measured and appropriate degree of flexibility for issuers that are making demonstrable progress toward regaining compliance while maintaining the integrity of existing standards, reduces the risk of unnecessary or premature delistings, promotes orderly markets and mitigates potential disruption to investors without weakening investor protections. [23 ] One commenter specifically states that some laddered strategies utilize a tranche of ETFs, which each have their own unique date parameters, and the dynamics and timing of such strategies have implications for beneficial shareholder activity as the strategy goes through its expected life cycle. [24 ] The commenter additionally states that later-dated ETFs are a part of the overall strategy, but would not be expected to attract assets in the same way as stand-alone products. [25 ]

The Exchange also states that NYSE Arca rules do not explicitly set forth the parameters of its staff review of a compliance plan and that NYSE Arca's internal policies provide NYSE Arca staff with discretion in determining how to handle failures to meet continued listing standards, [26 ] and that the Exchange's proposed rule change would better align its rules with NYSE Arca. [27 ] The Exchange states that, without the proposed rule change, issuers—and particularly those of ETPs with unique structural characteristics—might favor listing on other exchanges that provide greater flexibility in compliance timeframes, which could disadvantage the Exchange and reduce competition among listing venues. [28 ]

After careful review, the Commission finds that the proposed rule change is consistent with the requirements of the Act and the rules and regulations thereunder applicable to a national securities exchange. [29 ] In particular, the Commission finds that the proposed rule change is consistent with Sections 6(b)(5) of the Act which requires, among other things, that the rules of a national securities exchange be designed to prevent fraudulent and manipulative acts and practices, to promote just and equitable principles of trade, to remove impediments to and perfect the mechanism of a free and open market and a national market system, and, in general, to protect investors and the ( printed page 12652) public interest; and not be designed to permit unfair discrimination between customers, issuers, brokers or dealers. [30 ] The Exchange will grant the extended 180-day compliance period based on whether issuers are making genuine progress toward compliance, and such extensions can minimize the likelihood of market disruptions while maintaining meaningful compliance pressure through Exchange Staff's ongoing review of beneficial holder trends. Additionally, discretion in extending the compliance period beyond the initial 180 days already exists on another exchange. For these reasons, the Commission finds that the proposed rule change is consistent with the requirements of the Act.

IV. Conclusion

It is therefore ordered, pursuant to Section 19(b)(2) of the Act [31 ] that the proposed rule change (SR-CboeBZX-2026-005) be, and hereby is, approved.

For the Commission, by the Division of Trading and Markets, pursuant to delegated authority. [32 ]

Vanessa A. Countryman,

Secretary.

Footnotes

1. 15 U.S.C. 78s(b)(1).

Back to Citation 2. 17 CFR 240.19b-4.

Back to Citation 3.

                     
                    See 
                     Securities Exchange Act Release No. 104744 (January 29, 2026), [91 FR 4990](https://www.federalregister.gov/citation/91-FR-4990) (February 3, 2026) (“Notice”). *See also* Exchange Rule 14.12(b)(7) (defining “Listing Qualifications Department”); Exchange Rule 14.1(a)(3) (defining “Company” as the issuer of a security listed or applying to list on the Exchange, includes an issuer that is not incorporated, such as, for example, a limited partnership). The “beneficial holders” continued listing requirement refers to the record and/or beneficial holders requirement. 
                    See 
                     Exchange Rules 14.11(b)(9)(B)(i)(a), 14.11(c)(9)(B)(i)(a), 14.11(e)(4)(I)(i), 14.11(e)(5)(E)(ii)(a), 14.11(e)(6)(E)(ii)(a), 14.11(e)(7)(E)(ii)(a), 14.11(e)(8)(D)(ii)(a), 14.11(e)(9)(D)(ii)(a)(1), 14.11(e)(10)(E)(ii)(d)(1), 14.11(f)(2)(D)(ii)(a), 14.11(f)(4)(C)(ii)(a), 14.11(i)(4)(B)(iii)(a), 14.11(k)(4)(B)(ii)(a), 14.11(l)(4)(B)(i)(c), 14.11(m)(4)(B)(iv)(a), and 14.11(n)(4)(B)(i)(c).

Back to Citation 4.

                     
                    See 
                     Letter to Vanessa Countryman, Secretary, Commission, from Kevin Ehrlich, Managing Director, Asset Management Group of the Securities Industry and Financial Markets Association, dated February 24, 2026 (“SIFMA Letter”) and Letter to Vanessa Countryman, Secretary, Commission, from Stuart S. Parker, President, PGIM Investments LLC, dated February 24, 2026 (“PGIM Letter”). Comments received on the proposed rule change are available at *[https://www.sec.gov/​rules-regulations/​public-comments/​sr-cboebzx-2026-005](https://www.sec.gov/rules-regulations/public-comments/sr-cboebzx-2026-005).*

Back to Citation 5.

                     
                    See 
                     Notice at 4990-91.

Back to Citation 6. See id. at 4991.

Back to Citation 7. See id.

Back to Citation 8. See id. A Company currently under review by an Adjudicatory Body for an Exchange Staff Delisting Determination will not be eligible for this additional extension. If Exchange Staff grants an extension, it will inform the Company in writing of the basis for granting the extension and the terms of the extension. See id.

Back to Citation 9. See id.

Back to Citation 10. See id.

Back to Citation 11. See id.

Back to Citation 12. See id. The Exchange defines Outcome Strategy ETPs as multiple ETPs listed by an issuer that are each designed to provide (i) a pre-defined set of returns; (ii) over a specified outcome period; (iii) based on the performance of the same underlying instruments; and (iv) each employ the same outcome strategy for achieving the pre-defined set of returns.

Back to Citation 13. See id.

Back to Citation 14. See id.

Back to Citation 15. See id.

Back to Citation 16. See id.

Back to Citation 17. See id.

Back to Citation 18. See id. at 4993.

Back to Citation 19. See id.

Back to Citation 20. See id. at 4991 and 4992-93. The Exchange also states that the minimum beneficial holder requirement itself remains unchanged at 50 beneficial holders, and all other continued listing standards continue to apply without modification. See id. at 4992-93. The Exchange further states that companies currently under review by an Adjudicatory Body for an Exchange Staff Delisting Determination are ineligible for the additional extension, ensuring that the extended compliance period is not used to indefinitely delay delisting proceedings. See id.

Back to Citation 21.

                     
                    See 
                     SIFMA Letter and PGIM Letter.

Back to Citation 22.

                     
                    See 
                     SIFMA Letter at 1-2.

Back to Citation 23.

                     
                    See 
                     PGIM Letter at 2.

Back to Citation 24.

                     
                    See 
                     SIFMA Letter at 2.

Back to Citation 25. See id. at 2.

Back to Citation 26.

                     
                    See 
                     Notice at 4991-92 (citing 2025_NYSE_Arca_Listed_ETP_Compliance_Guidance_Letter.pdf which states that NYSE Arca staff will conduct its own review and make a determination on how to proceed with non-compliance with continued listing standards).

Back to Citation 27. See id. at 4992.

Back to Citation 28. See id. at 4993-94.

Back to Citation 29. 15 U.S.C. 78f(b). In approving this proposed rule change, the Commission has considered the proposed rule's impact on efficiency, competition, and capital formation.
See 15 U.S.C. 78c(f).

Back to Citation 30. 15 U.S.C. 78f(b)(5).

Back to Citation 31. 15 U.S.C. 78s(b)(2).

Back to Citation 32. 17 CFR 200.30-3(a)(12).

Back to Citation [FR Doc. 2026-05022 Filed 3-13-26; 8:45 am]

BILLING CODE 8011-01-P

Published Document: 2026-05022 (91 FR 12650)